We are live on
!
Find out more
OAG
Orbis Allan Gray Portfolio holdings
AUM
$29.1B
1-Year Est. Return
60.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+60.8%
3 Year Est. Return
+154.65%
5 Year Est. Return
+203.47%
10 Year Est. Return
+909.03%
AUM
$14.3B
AUM Growth
+$786M
(+5.8%)
Cap. Flow
-$887M
Cap. Flow
% of AUM
-6.19%
Top 10 Holdings %
Top 10 Hldgs %
67.76%
Holding
67
New
7
Increased
20
Reduced
21
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$314M |
| 2 |
Fomento Económico Mexicano
FMX
|
+$174M |
| 3 |
British American Tobacco
BTI
|
+$135M |
| 4 |
Altria Group
MO
|
+$122M |
| 5 |
APA Corp
APA
|
+$63.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$714M |
| 2 |
NetEase
NTES
|
+$302M |
| 3 |
XPO
XPO
|
+$161M |
| 4 |
Dollar General
DG
|
+$107M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 32.72% |
| 2 | Healthcare | 21.11% |
| 3 | Industrials | 13.77% |
| 4 | Consumer Staples | 7.32% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Altria Group
MO
$113B
| $129M | 0.9% |
+2,581,673
| New | +$122M |
|
27
BP
BP
$109B
| $105M | 0.73% |
2,779,863
+7,396
| +0.3% | +$281K |
|
28
Ryanair
RYAAY
$28.8B
| $103M | 0.72% |
2,946,405
+914,040
| +45% | +$29.3M |
|
29
SLB Ltd
SLB
$81.6B
| $97.7M | 0.68% |
2,431,091
-105,435
| -4% | -$3.76M |
|
|
B
30
Barrick Mining
B
$77.9B
| $76.1M | 0.53% |
4,095,969
+7,982
| +0.2% | +$137K |
|
31
Edison International
EIX
$28.4B
| $34M | 0.24% |
450,198
-442,107
| -50% | -$31.3M |
|
|
SOHU
32
Sohu.com
SOHU
$368M
| $27.4M | 0.19% |
2,448,116
-357,756
| -13% | -$3.75M |
|
33
Honda
HMC
$40.7B
| $26.7M | 0.19% |
941,663
+228,298
| +32% | +$6.36M |
|
|
CS
34
DELISTED
Credit Suisse Group
CS
| $21.2M | 0.15% |
1,578,302
| – | – |
|
|
BORR
35
Borr Drilling
BORR
$1.4B
| $21.1M | 0.15% |
1,163,308
| – | – |
|
36
ING
ING
$100B
| $20.5M | 0.14% |
1,699,902
| – | – |
|
37
Korea Electric Power
KEP
$15.3B
| $20.4M | 0.14% |
1,724,911
| – | – |
|
38
Toyota
TM
$227B
| $17.5M | 0.12% |
124,670
+68,967
| +124% | +$9.63M |
|
|
DO
39
DELISTED
Diamond Offshore Drilling
DO
| $17.4M | 0.12% |
2,424,107
-201,841
| -8% | -$1.17M |
|
40
Wheaton Precious Metals
WPM
$71.8B
| $17.1M | 0.12% |
527,268
+470,378
| +827% | +$12.9M |
|
|
BMY.RT
41
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $16.6M | 0.12% |
+5,514,627
| New | +$14.3M |
|
42
Teekay
TK
$1.12B
| $8.16M | 0.06% |
1,533,018
| – | – |
|
43
KB Financial Group
KB
$42.6B
| $7.64M | 0.05% |
184,581
-3,467
| -2% | -$133K |
|
44
AMC Entertainment Holdings
AMC
$2.41B
| $7.05M | 0.05% |
+97,443
| New | +$8.58M |
|
|
VGR
45
DELISTED
Vector Group Ltd.
VGR
| $6.97M | 0.05% |
+733,964
| New | +$6.42M |
|
|
VAL
46
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $6.87M | 0.05% |
1,047,172
-1,055,671
| -50% | -$5.14M |
|
47
Berkshire Hathaway Class B
BRK.B
$1.08T
| $6.32M | 0.04% |
27,913
+3,927
| +16% | +$853K |
|
|
CRC
48
DELISTED
California Resources Corporation
CRC
| $5.55M | 0.04% |
614,186
-271,058
| -31% | -$2.2M |
|
49
Chubb
CB
$131B
| $5.01M | 0.04% |
32,170
| – | – |
|
50
Comcast
CMCSA
$93.7B
| $4.54M | 0.03% |
100,858
+87,199
| +638% | +$3.88M |
|
Similar funds
TCIIS
GMC
FAM
Orbis Allan Gray's Q4 2019 Portfolio in Review
As of Q4 2019, Orbis Allan Gray held 67 positions worth $14.3B, up 5.8% from $13.5B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Orbis Allan Gray withdrew a net $887M in Q4 2019, closing 4 positions and reducing 21 holdings. Its most notable exit was Celgene Corp, an estimated $714M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Orbis Allan Gray opened a new position in Bristol-Myers Squibb worth $352M.
- Orbis Allan Gray's largest Q4 2019 buy was Bristol-Myers Squibb: 5,481,869 shares worth $352M.
- Orbis Allan Gray added most to Fomento Económico Mexicano in Q4 2019, an estimated $174M increase.
- Orbis Allan Gray's biggest Q4 2019 reduction was NetEase, cutting an estimated $302M.
- Orbis Allan Gray fully exited Celgene Corp in Q4 2019, selling an estimated $714M.
- Orbis Allan Gray's ten largest holdings make up 68% of its $14.3B portfolio in Q4 2019.
- Orbis Allan Gray opened 7 new positions and closed 4 in Q4 2019.
- Orbis Allan Gray's portfolio value rose 5.8% quarter-over-quarter to $14.3B.
Based on Orbis Allan Gray's 13F filing for Q4 2019, filed 14 Feb 2020.